Description

BRUFOCAN 400 MG

Indications

BRUFOCAN 400 MG is primarily indicated for the management of pain and inflammation associated with various conditions. These may include osteoarthritis, rheumatoid arthritis, and acute musculoskeletal disorders. Additionally, it is used to alleviate mild to moderate pain, such as headaches, dental pain, and postoperative pain. Its anti-inflammatory properties make it suitable for treating conditions characterized by inflammation.

Mechanism of Action

BRUFOCAN 400 MG contains the active ingredient, ibuprofen, which is classified as a non-steroidal anti-inflammatory drug (NSAID). The primary mechanism of action involves the inhibition of cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. These enzymes are crucial for the conversion of arachidonic acid to prostaglandins, which are mediators of inflammation, pain, and fever. By inhibiting COX activity, BRUFOCAN reduces the synthesis of prostaglandins, thereby alleviating pain and inflammation.

Pharmacological Properties

BRUFOCAN 400 MG exhibits several pharmacological properties that contribute to its effectiveness in treating pain and inflammation. The drug is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations typically achieved within 1 to 2 hours after oral administration. It is extensively metabolized in the liver, primarily through the cytochrome P450 system, and excreted via the kidneys. The half-life of ibuprofen is approximately 2 to 4 hours, which supports its dosing schedule for effective pain management.

Contraindications

BRUFOCAN 400 MG is contraindicated in patients with known hypersensitivity to ibuprofen or any other components of the formulation. It should not be used in individuals with a history of gastrointestinal bleeding or peptic ulcer disease, as NSAIDs can exacerbate these conditions. Additionally, it is contraindicated in patients with severe renal impairment, active liver disease, or those who have experienced asthma attacks, urticaria, or allergic reactions following the administration of aspirin or other NSAIDs.

Side Effects

While BRUFOCAN 400 MG is generally well-tolerated, it may cause side effects in some individuals. Common side effects include gastrointestinal disturbances such as nausea, vomiting, dyspepsia, and abdominal pain. More serious side effects can occur, including gastrointestinal bleeding, renal impairment, and cardiovascular events. Patients should be monitored for signs of an allergic reaction, such as rash, itching, or swelling. If any severe side effects occur, immediate medical attention should be sought.

Dosage and Administration

The recommended dosage of BRUFOCAN 400 MG varies depending on the condition being treated and the patient’s age and overall health. For adults, the typical starting dose is 400 mg taken orally every 6 to 8 hours as needed, not exceeding 1200 mg per day. For children, the dosage is based on body weight and should be determined by a healthcare professional. It is advisable to take BRUFOCAN with food or milk to minimize gastrointestinal irritation. Patients should adhere to the prescribed dosage and consult their healthcare provider if symptoms persist or worsen.

Interactions

BRUFOCAN 400 MG may interact with various medications, potentially altering their effects or increasing the risk of adverse reactions. Notable interactions include anticoagulants such as warfarin, which may increase the risk of bleeding. Other NSAIDs, corticosteroids, and certain antihypertensive medications may also interact with ibuprofen, leading to reduced efficacy or increased side effects. It is essential for patients to inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements, to avoid potential interactions.

Precautions

Before starting BRUFOCAN 400 MG, patients should discuss their medical history with their healthcare provider, particularly if they have a history of cardiovascular disease, hypertension, liver or kidney disease, or gastrointestinal disorders. Caution is advised in elderly patients, as they may be more susceptible to the side effects of NSAIDs. Additionally, BRUFOCAN should be used with caution in pregnant or breastfeeding women, as its safety has not been fully established in these populations. Regular monitoring may be necessary for patients on long-term therapy to assess renal function and gastrointestinal health.

Clinical Studies

Clinical studies have demonstrated the efficacy of BRUFOCAN 400 MG in managing pain and inflammation. A randomized controlled trial involving patients with osteoarthritis showed significant improvement in pain scores and physical function compared to placebo. Another study highlighted the effectiveness of ibuprofen in treating postoperative pain, with patients reporting substantial relief within hours of administration. These studies underscore the role of BRUFOCAN as a valuable option for pain management in various clinical settings.

Conclusion

BRUFOCAN 400 MG is a widely used NSAID that provides effective relief from pain and inflammation associated with various medical conditions. Its mechanism of action, pharmacological properties, and clinical efficacy make it a valuable tool in pain management. However, it is essential for patients to be aware of potential side effects, contraindications, and drug interactions. Consulting with a healthcare provider is crucial to ensure safe and effective use of BRUFOCAN.